BCG 2nd Edition -TB vaccine- Application against tuberculosis and other diseases

¥3,300

BCG 2nd Edition -TB vaccine- Application against tuberculosis and other diseases

8月末発行。

 

Edited by

Takemasa Takii, Ph.D.

Jun-ichi Maeyama, Ph.D.

Saburo Yamamoto,PhD.

B5判/ 277頁

 

ISBN:978-4-87451-322-4

 

 

  • 数量:

 　Ten yeas have passed since the publication of the first edition, and there have been many advances in our understanding of the BCG vaccine. Hence, we  added contents about the safety and use of the BCG vaccine and its application to other diseases in this second edition, in addition to a revision of the contents of the first edition. The authors of this book are experts in the fields of BCG and TB research. 

 

 　This book is the only book that covers basic, clinical and epidemiologic studies of the BCG vaccine systematically. No other book covers the TB vaccine so comprehensively, from its birth up to future vaccine development. Finally, TB is not a past disease and has not been eradicated yet, it can still be considered a pandemic. We would be extremely thankful if this book is useful for persons engaged in the eradication of TB by helping them futher their understanding of  the TB vaccine and its future prospects.


Chapter 1　Historical background of Mycobacterium bovis BCG
　 Mary Jackson and Saburo Yamamoto
Chapter 2 　BCG vaccination in control of tuberculosis 　
　Toru Mori
Chapter 3　 BCG characterization　
　Mei Mei Ho
Chapter 4 　Report of the efficacy and safety for percutaneous use of BCG
　vaccine prepared from Tokyo 172-1 strain
　Shizuko Nakata, Katsutoshi Oshima, Naoki Nakada, et al
Chapter 5　 Adverse reactions after vaccination with Bacille Calmette-Guérin
　Osamu Tokunaga
Chapter 6 　Animal models in BCG-induced resistance to tuberculosis
　David N. McMurray
Chapter 7　 Immunological characteristics of two subpopulations of BCG
　Tokyo 172 with different RD16 regions in a guinea pig model of 
　pulmonary tuberculosis
　Toshiko Yamamoto, Christine McFarland, Lan Ly, et al
Chapter 8　 Lipid phenotypes of BCG strains and their host responses
　Nagatoshi Fujiwara
Chapter 9　 Development of new TB vaccines
　Takemasa Takii
Chapter 10　 Recombinant BCG vaccines
　Kazuhiro Matsuo
Chapter 11 　Toxicity study for BCG Tokyo, Danish, and Pasteur substrains
　in SCID mice
　Kazuhiro Matsuo
Chapter 12　 Mechanisms of action of intravesical BCG therapy for nonmuscle
　invasive bladder cancer
　Timothy L. Ratlif
Chapter 13 　Beneficial off-target effects of the BCG vaccine: type 1 diabetes
　and beyond
　Hiroyuki Takahashi and Denise L. Faustman
Chapter 14　 Bacterial factors regulating M. tuberculosis infection and persistence
　Akihito Nishiyama and Sohkichi Matsumoto
Chapter 15 　Host and bacterial factors regulating Mycobacterium tuberculosis
　infection and persistence
　Yuriko Ozeki, Mamiko Niki, and Sohkichi Matsumoto
Chapter 16　 Genetic diversity of Mycobacterium tuberculosis and its impact on
　adaptive evolution, vaccination efficacy, and population dynamics
　Takayuki Wada
Chapter 17 　Efficacy of BCG vaccination against leprosy and nontuberculous
　mycobacteria (NTM) infections
　Naoya Ohara
Chapter 18 　Administration methods of BCG vaccine and adjuvants
　Jun-ichi Maeyama

 

関連商品